RANBAXY LABORATORIES LTD.

RANBAXY LABORATORIES LTD. - Clarification

	< Back
26 Nov 2014
Ranbaxy Laboratories Ltd had earlier informed to the Stock Exchanges that the Company has filed a complaint against the US FDA in D.C. Federal Court and had also asked the Court for a temporary restraining order to prevent any further action by FDA until Ranbaxy's case is decided.<br/><br/>Ranbaxy Laboratories Ltd further submitted, "The Court has not granted Temporary Restraining Order to block FDA approval for other ANDAs for generic version of Nexium and Valganciclovir. However, the Court ordered the parties to the suit to agree up on a schedule for filing additional legal briefs addressing Ranbaxy's request for a preliminary injunction by Friday, November 21, 2014."
View all announcements for RANBAXY LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us